Luz E. Liriano-Ward

Profile image for Luz E. Liriano-Ward

Luz E. Liriano-Ward, MD

Nephrology



  • Transplant Nephrologist
  • Associate Professor of Medicine

Montefiore Medical Center
111 East 210th Street
Bronx, NY 10467-2401
Directions

Montefiore Einstein

About

Researcher or Academic Professional?

View Faculty Profile

Click here to learn more about this specialist's research and educational efforts at the Albert Einstein College of Medicine.

Luz Liriano-Ward, MD received her MD degree at Weill Cornell Medical College. She then completed internal medicine residency at NYU Langone Medical Center, followed by 2-years of nephrology fellowship and 1 year of transplant nephrology at Mount Sinai Hospital – Icahn School of Medicine. Dr. Liriano-Ward is a UNOS certified transplant nephrologist. Dr. Liriano-Ward is board certified by the American Board of Internal Medicine and the American Board of Nephrology. Dr. Liriano-Ward is a member of the American Society of nephrology and the American Society of Transplantation. She has special interest in medical education and acts as the director for the transplant nephrology fellowship at Montefiore Medical Center. She is also the director for the medical students’ nephrology rotation at Albert Einstein College of medicine / Montefiore Medical Center. She serves in multiple committees at the local and national level, including the Transplant Nephrology Fellowship Training Accreditation Program (TNFTAP) for the American Society of Transplantation. 

Gender: Female

Credentials

Titles and Positions

  • Transplant Nephrologist
  • Associate Professor of Medicine

Education and Training

  • Medical Education Weill Medical College of Cornell University
  • Fellowship Mount Sinai School of Medicine
  • Residency NYU Langone Medical Center

Areas of Expertise

Specialties

  • Nephrology

Clinical Focus

Kidney and Pancreas Transplantation

Research Focus

Short term and long term outcomes of deceased donor kidney transplantation. Pancreas transplant outcomes on Type 2 diabetics compared to type 1 diabetics. The use of SGLT2- inhibitor in kidney transplant recipients. 

Locations